Achieve Life Sciences Inc (ACHV)
4.735
+0.04
(+0.96%)
USD |
NASDAQ |
May 03, 16:00
4.735
0.00 (0.00%)
After-Hours: 20:00
Achieve Life Sciences Free Cash Flow (Quarterly): -4.37M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -4.37M |
September 30, 2023 | -5.151M |
June 30, 2023 | -6.676M |
March 31, 2023 | -8.303M |
December 31, 2022 | -11.14M |
September 30, 2022 | -11.31M |
June 30, 2022 | -8.34M |
March 31, 2022 | -6.779M |
December 31, 2021 | -5.218M |
September 30, 2021 | -8.694M |
June 30, 2021 | -9.076M |
March 31, 2021 | -6.452M |
December 31, 2020 | -2.48M |
September 30, 2020 | -4.338M |
June 30, 2020 | -2.21M |
March 31, 2020 | -4.463M |
December 31, 2019 | -3.415M |
September 30, 2019 | -3.072M |
June 30, 2019 | -3.839M |
March 31, 2019 | -4.943M |
December 31, 2018 | -3.551M |
September 30, 2018 | -2.981M |
June 30, 2018 | -1.904M |
March 31, 2018 | -2.233M |
December 31, 2017 | -3.623M |
Date | Value |
---|---|
September 30, 2017 | -5.455M |
June 30, 2017 | -0.018M |
March 31, 2017 | -0.011M |
December 31, 2016 | 22.54M |
September 30, 2016 | -7.267M |
June 30, 2016 | -6.389M |
March 31, 2016 | -9.087M |
December 31, 2015 | -10.76M |
September 30, 2015 | -8.668M |
June 30, 2015 | 16.60M |
March 31, 2015 | -6.649M |
December 31, 2014 | -6.946M |
September 30, 2014 | -5.773M |
June 30, 2014 | -2.972M |
March 31, 2014 | -1.699M |
December 31, 2013 | -7.557M |
September 30, 2013 | -10.24M |
June 30, 2013 | -7.582M |
March 31, 2013 | -10.80M |
December 31, 2012 | -9.674M |
September 30, 2012 | -12.96M |
June 30, 2012 | -13.77M |
March 31, 2012 | -7.383M |
December 31, 2011 | -4.443M |
September 30, 2011 | -6.20M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-11.31M
Minimum
Sep 2022
-2.21M
Maximum
Jun 2020
-6.070M
Average
-5.218M
Median
Dec 2021
Free Cash Flow (Quarterly) Benchmarks
Accelerate Diagnostics Inc | -7.865M |
Atossa Therapeutics Inc | -5.571M |
ENDRA Life Sciences Inc | -2.182M |
Perspective Therapeutics Inc | -9.097M |
Electromed Inc | 3.384M |